Relative Bioavailability of Dabigatran Etexilate Capsules With and Without Quinidine Sulfate Tablets and to Measure the Effect of Quinidine on the Absorption of Fexofenadine in Healthy Male and Female Volunteers

NCT02171546 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Dabigatran etexilate capsules
DRUG: Quinidine sulfate tablets
DRUG: Fexofenadine tablets

Sponsor

Boehringer Ingelheim